Literature DB >> 25502458

TRPC Channels: Prominent Candidates of Underlying Mechanism in Neuropsychiatric Diseases.

Chang Zeng1,2, Fafa Tian3, Bo Xiao4.   

Abstract

Alterations in intracellular Ca(2+) concentration ([Ca(2+)]i) play a crucial role in fundamental cellular events from transcriptional regulation to migration and proliferation. The transient receptor potential (TRP) channels contribute to changes in [Ca(2+)]i by providing or modulating Ca(2+) entry pathways, as well as by releasing Ca(2+) from intracellular stores. On the basis of sequence homology, the TRP family can be divided into seven subfamilies: the TRPC ("canonical") family, the TRPV ("vanilloid") family, the TRPM ("melastatin") family, the TRPP ("polycystin") family, the TRPML ("mucolipin") family, the TRPA ("ankyrin") family, and the TRPN ("NOMPC") family. In this review, we focus on the physiology and pathophysiology of mammalian TRPC channels in the nervous system. Seven mammalian TRPC proteins (TRPC1-7) have been described and are widely distributed in the brain from early embryonic days till adulthood, with the exception of TRPC2. TRPC channels are nonselective Ca(2+)-permeable channels, which can be activated by G-protein-coupled receptors and receptor tyrosine kinases. These channels have been reported to act as essential cellular sensors in multiple processes during neuronal development, including neural stem cell proliferation and differentiation, neuronal survival, neurite outgrowth and axon path finding, and synaptogenesis. Not surprisingly, studies on these channels also provide new insights into underlying mechanisms of various neuropsychiatric disorders. The present review summarizes the expressions of all TRPC subtypes in different brain regions and different neural cell types, aiming to serve as a useful reference for future studies in this field. We also discuss the most updated evidence implicating involvement of TRPC channels in the generation of pathophysiological states in nervous system and their potentials as being promising targets for drug development.

Entities:  

Keywords:  2-APB; CNS; Hyperforin; SKF96365; TRPC channels

Mesh:

Substances:

Year:  2014        PMID: 25502458     DOI: 10.1007/s12035-014-9004-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  187 in total

1.  A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK.

Authors:  L A Pérez Jurado; Y K Wang; R Peoples; A Coloma; J Cruces; U Francke
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

Review 2.  TRP channels: new potential therapeutic approaches in CNS neuropathies.

Authors:  Maria Beatrice Morelli; Consuelo Amantini; Sonia Liberati; Matteo Santoni; Massimo Nabissi
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-03       Impact factor: 4.388

3.  Epidermal growth factor induces tyrosine phosphorylation, membrane insertion, and activation of transient receptor potential channel 4.

Authors:  Adam F Odell; Judith L Scott; Dirk F Van Helden
Journal:  J Biol Chem       Date:  2005-09-06       Impact factor: 5.157

4.  HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells.

Authors:  G Zauli; P Secchiero; L Rodella; D Gibellini; P Mirandola; M Mazzoni; D Milani; D R Dowd; S Capitani; M Vitale
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

5.  Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers.

Authors:  O Tutdibi; H Brinkmeier; R Rüdel; K J Föhr
Journal:  J Physiol       Date:  1999-03-15       Impact factor: 5.182

6.  TRPC1 inhibits apoptotic cell degeneration induced by dopaminergic neurotoxin MPTP/MPP(+).

Authors:  Senthil Selvaraj; John A Watt; Brij B Singh
Journal:  Cell Calcium       Date:  2009-08-19       Impact factor: 6.817

7.  TRPC3-interacting triadic proteins in skeletal muscle.

Authors:  Jin Seok Woo; Do Han Kim; Paul D Allen; Eun Hui Lee
Journal:  Biochem J       Date:  2008-04-15       Impact factor: 3.857

8.  Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells.

Authors:  D M Kovacs; H J Fausett; K J Page; T W Kim; R D Moir; D E Merriam; R D Hollister; O G Hallmark; R Mancini; K M Felsenstein; B T Hyman; R E Tanzi; W Wasco
Journal:  Nat Med       Date:  1996-02       Impact factor: 53.440

9.  Mice lacking Homer 1 exhibit a skeletal myopathy characterized by abnormal transient receptor potential channel activity.

Authors:  Jonathan A Stiber; Zhu-Shan Zhang; Jarrett Burch; Jerry P Eu; Sarah Zhang; George A Truskey; Malini Seth; Naohiro Yamaguchi; Gerhard Meissner; Ripal Shah; Paul F Worley; R Sanders Williams; Paul B Rosenberg
Journal:  Mol Cell Biol       Date:  2008-02-11       Impact factor: 4.272

Review 10.  Neuronal calcium signaling: function and dysfunction.

Authors:  Marisa Brini; Tito Calì; Denis Ottolini; Ernesto Carafoli
Journal:  Cell Mol Life Sci       Date:  2014-01-19       Impact factor: 9.261

View more
  15 in total

1.  Derivatives of Piperazines as Potential Therapeutic Agents for Alzheimer's Disease.

Authors:  Elena Popugaeva; Daria Chernyuk; Hua Zhang; Tatyana Y Postnikova; Karina Pats; Elena Fedorova; Vladimir Poroikov; Aleksey V Zaitsev; Ilya Bezprozvanny
Journal:  Mol Pharmacol       Date:  2019-01-29       Impact factor: 4.436

Review 2.  TRPC channels: Structure, function, regulation and recent advances in small molecular probes.

Authors:  Hongbo Wang; Xiaoding Cheng; Jinbin Tian; Yuling Xiao; Tian Tian; Fuchun Xu; Xuechuan Hong; Michael X Zhu
Journal:  Pharmacol Ther       Date:  2020-01-28       Impact factor: 12.310

3.  Potential Treatment for Neuropsychiatry Disorders with TRPC5 Modulators.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2016-05-12       Impact factor: 4.345

4.  Increased TRPM4 Activity in Cerebral Artery Myocytes Contributes to Cerebral Blood Flow Reduction After Subarachnoid Hemorrhage in Rats.

Authors:  Yi Gong; Ming-Yue Du; Hua-Lin Yu; Zhi-Yong Yang; Yu-Jin Li; Lei Zhou; Rong Mei; Li Yang; Fei Wang
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

5.  Investigating a Genetic Link Between Alzheimer's Disease and CADASIL-Related Cerebral Small Vessel Disease.

Authors:  Paul J Dunn; Rodney A Lea; Neven Maksemous; Robert A Smith; Heidi G Sutherland; Larisa M Haupt; Lyn R Griffiths
Journal:  Mol Neurobiol       Date:  2022-09-29       Impact factor: 5.682

6.  Inhibition of TRPC1-Dependent Store-Operated Calcium Entry Improves Synaptic Stability and Motor Performance in a Mouse Model of Huntington's Disease.

Authors:  Jun Wu; Daniel Ryskamp; Lutz Birnbaumer; Ilya Bezprozvanny
Journal:  J Huntingtons Dis       Date:  2018

Review 7.  Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids.

Authors:  Elzbieta Rebas; Tomasz Radzik; Tomasz Boczek; Ludmila Zylinska
Journal:  Curr Neuropharmacol       Date:  2017-11-14       Impact factor: 7.363

8.  TRPC1 Deletion Causes Striatal Neuronal Cell Apoptosis and Proteomic Alterations in Mice.

Authors:  Dian Wang; Haitao Yu; Benhong Xu; Hua Xu; Zaijun Zhang; Xiaohu Ren; Jianhui Yuan; Jianjun Liu; Yi Guo; Peter S Spencer; Xifei Yang
Journal:  Front Aging Neurosci       Date:  2018-03-20       Impact factor: 5.750

9.  S-adenosyl methionine regulates calcium channels and inhibits uterine smooth muscle contraction in rats with infectious premature delivery through the transient receptor protein 3/protein kinase Cβ/C-kinase-activated protein phosphatase-1 inhibitor of 17 kDa signaling pathway.

Authors:  Jing Ge; Tao Han; Xiaoqiu Li; Lili Shan; Jinhuan Zhang; Yan Hong; Yanqiu Xia; Jun Wang; Mingxiao Hou
Journal:  Exp Ther Med       Date:  2018-05-14       Impact factor: 2.447

10.  RNA-seq analysis reveals TRPC genes to impact an unexpected number of metabolic and regulatory pathways.

Authors:  Karina Formoso; Sebastian Susperreguy; Marc Freichel; Lutz Birnbaumer
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.